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Blood-oxygenation-level-dependent functional magnetic resonance
imaging is a noninvasive technique that has become increasingly
popular in the neurosciences. It measures the proportion of
oxygenated haemoglobin in speciﬁc areas of the brain, mirroring
blood ﬂow and therefore function. Here we review how the
ﬁndings from functional studies impact on areas of gynaecological
practice as diverse as chronic pain, continence, and premenstrual
dysphoric disorder. Finally we review some of the more novel
applications of the technique, such as imaging of pelvic ﬂoor
function and the effects of hypoxia on the fetus.
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Introduction
Blood oxygenation level dependent (BOLD) functional mag-
netic resonance imaging (fMRI) is a functional imaging tech-
nique that is becoming increasingly popular especially in the
neuroscience ﬁeld of research on human brain function. Here
we will give an overview of the physics of thetechnique and then
review some of its current and future applications that are either
directly or indirectly applicable to obstetrics and gynaecology.
Blood oxygenation level dependent
fMRI
MRI is a technique commonly used in clinical practice to
investigate structural abnormalities. It relies on the different
magnetic properties of hydrogen ions in different tissues (e.g.
water, fat, bone) to form images with contrast between the
tissues, without the need for radioactivity. Although an
incredibly useful diagnostic tool in a variety of clinical situa-
tions, standard MRI scans are unable to tell us anything about
function. There are many clinical conditions, such as primary
dysmenorrhoea, where structurally the organ appears normal
yet symptoms are associated with its function. Previously, the
best assessment of function was the patients’ subjective
report. However, with the observation of the BOLD response
in 1990,1 a new era of functional imaging has begun.
It is well known that metabolic activity uses oxygen; there-
fore, blood in the vicinity of metabolically active tissues will
have a different proportion of oxygenated to deoxygenated hae-
moglobin (Hb) than that surrounding quiescent tissue. These
two forms of Hb have different magnetic properties and this is
used as a form of endogenous contrast to allow us to image
function rather than structure: BOLD fMRI. For example, activ-
i t yi nas p e c i ﬁ cb r a i na r e ai sa s s o c i a t e dw i t ha ni n c r e a s ei nb l o o d
ﬂow to this area, which provides the oxygen and glucose nec-
essary for neuronal activity. In fact, the increase in blood ﬂow
exceeds the oxygen requirement and there is therefore an
increase in oxygenated Hb relative to deoxygenated Hb in met-
abolically active areas. This reduction in deoxygenated Hb leads
to a reduced magnetic susceptibility and an increased MR sig-
nal, which is known as the BOLD response2 (Figure1).
The fact that BOLD fMRI has good spatial (mm) and tem-
poral resolution, is reproducible, and requires no exogenous
contrast or radioactivity has made it a popular technique for
imaging brain function, both in single-session studies and
longitudinal experiments (such as pre- and post-drug treat-
ment). Much work has been performed to investigate the
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such that we can say with conﬁdence that the BOLD response
closely represents neuronal activity.
The development of MR sequences to optimise signal to
noise ratio, the increasing availability of high-power magnets
(3 or even 7 Tesla), and the introduction of relatively intuitive
analysis tools has allowed the technique to be adopted around
the world and used in a variety of different ﬁelds. Over the last
decade, BOLD contrast has also been used to investigate met-
abolic activity of non-neuronal tissues, some of which will be
discussed below.
Brain imaging studies
Pain
Pain research is a ﬁeld that has embraced the use of brain
imaging techniques, from early positron emission topography
experiments to subtle modern fMRI studies. Both the neural
correlates of acute pain3 and the aberrant processing that
occurs in chronic pain conditions4,5 have been investigated.
These techniques allow either the role of the whole brain,
brainstem, or spinal cord to be examined or the contribution
of speciﬁc brain areas such as the amygdala, insula, or hippo-
campus to be considered. Furthermore, complex cognitive
paradigms can also be included such that the speciﬁc effect
of modulating, for example, anxiety or attention, can also be
seen. When considering clinical pain conditions, experimen-
tal stimuli that represent pain in general, for example, thermal
stimuli to the inner arm, or a more speciﬁcally relevant pain
such as balloon distension of the rectum in patients with
irritable bowel syndrome (IBS) can be used. Both methods
can give interesting and potentially therapeutically useful
results. This can be especially useful in conditions where no
clear pathological cause exists. Many different pain conditions
have been investigated in these studies; however, here we shall
consider only two that are gynaecologically relevant.
Vulval vestibulitis syndrome (VVS) is a frustrating condi-
tion for patients and their doctors, with little to be found on
examination or even histology if surgery is undertaken. Yet,
an fMRI study has conﬁrmed that the increase in pain and
unpleasantness in response to pressure on the vestibule
reported by women with VVS (as opposed to pain-free
women) is also associated with increased brain activation in
response to these stimuli (Figure 2).6 This suggests that an
augmentation of genital sensory processing exists and points
us towards the search for an effective centrally acting drug
rather than a local treatment.
IBS is a common cause of pelvic pain, which can show
cyclical variations and thus present to the gynaecologist. It
has been the subject of a number of fMRI studies (partly
because of interest in the concept of the ‘brain–gut axis’ Figure 1. Physiological basis of the BOLD response. HbO2, oxygenated
Hb; Hbr, deoxygenated Hb; [Hbr], concentration of Hbr; CBV, cerebral
blood volume.
Figure 2. Different brain activation patterns in response to painful pres-
sure in women with VVS and healthy controls. Signiﬁcant changes are
circled in yellow (threshold t value = 4.5). Colour bar shows signiﬁcance.
S2, secondary somatosensory cortex; IC, insularcortex; IPL, inferior parietal
lobe; BA44, Brodmann’s area 44. Reproduced with permission from Pukall
CF, et al. Pain 2005;115:118–27.6
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compared with other viscera such as the oesophagus or pan-
creas) and thus much greater knowledge and understanding
exist about this condition than is the case for other visceral
pain syndromes. In line with findings from other chronic
pain conditions and the concept of visceral hypersensitivity,
enhanced brain activation in response to both somatic and
visceral7,8 stimuli has been demonstrated in patients with IBS.
Arguably more interesting, however, is the additional ﬁnding
that subgroups of patients with IBS (diarrhoea or constipa-
tion predominant) show differing abnormal endogenous pain
inhibitory mechanisms,9 suggesting that different treatments
may be successful in these groups. Amitriptyline is one of
the few proven treatments for IBS, and thus, it is reassuring
that patients with IBS treated with this drug, whose symp-
toms improve, show a normalisation of their brain response
to painful rectal stimuli.10 This also lends support to the
idea that fMRI may be useful as a biomarker in drug
development.11
Although, to date, no study on dysmenorrhoea has been
published, two studies have examined the effects of the men-
strual cycle on pain perception.12,13 Despite the fact that in
one of these, there was no signiﬁcant difference in pain rat-
ings, different patterns of activation in response to pain were
seen at different cycle phases in both studies. Therefore, hor-
monal status may have a role in altering the pain experience,
perhaps explaining the frequently observed cyclical variation
in symptoms from non-gynaecological organs such as occurs
in temporomandibular joint dysfunction14 and migraine.15
Continence
The pelvic mechanisms of continence are now relatively well
understood, and it is known that in healthy women, this is
under higher control. The speciﬁc brain areas involved in
these mechanisms have now been identiﬁed in a series of
fMRI studies.
The urge to void has been associated with activity in a net-
work of areas in both the brain and the brainstem and con-
scious suppression of this urge with strong activity in the
superior frontal lobe.16 Unsurprisingly, voluntary contraction
of pelvic ﬂoor muscles in healthy subjects (both men and
women) is associated with activation of the supplementary
motor area and the primary motor cortex; however, other
areas of activation are also seen, presumably reﬂecting atten-
tive processing and evaluation of visceral sensations. Interest-
ingly, there is no correlation between the bladder volume at
the time of pelvic ﬂoor contraction and brain activation, and
no signiﬁcant difference in activation patterns between men
and women.17,18
These mechanistic studies in healthy subjects have now
been extended into women with stress urinary incontinence
to examine the effects of pelvic ﬂoor muscle training. After
a12-week programme, more focussed activations wereseen in
the areas of the primary motor and somatosensory cortices,
which represent the lower urogenital tract; these increases also
correlated with increased electromyographic activity recorded
from the pelvic ﬂoor muscles themselves. Furthermore,
reduced activity was seen in areas associated with emotional
arousal, suggesting that these changes represent more than
just pure motor learning.19 Women with urge incontinence
have also been shown to have abnormal brain responses to
bladder ﬁlling, with disruption of the connections seen in
healthy women and activations thought to represent recruit-
ment of alternative pathways to maintain bladder control.20
Studies such as these can therefore inform clinical practice
by validating current treatments and by suggesting possible
combinations of, for example, physiotherapy, pharmacologi-
cal, and psychological treatments. A more detailed under-
standing of the role of the brain, brainstem, and spinal cord
in continence mechanisms may also help in the development
of novel treatments for urinary incontinence secondary to
brain or spinal cord injury.
Premenstrual dysphoric disorder
Premenstrualdysphoricdisorder(PMDD),althoughapsychi-
atric diagnosis, frequently presents to the gynaecologist as
part of a spectrum of menstrually related disorders or is dis-
cussed in the context of hormonal treatment of other symp-
toms. There is no evidence that abnormal levels of hormones
occur in this condition (e.g. unlike in depression associated
with hypothyroidism); instead, it appears that some women
are more sensitive to the mood-destabilising effects of these
hormones.21 Comparing women with PMDD to asymptom-
atic women in both pre- and postmenstrual phases, clear
differences can be seen in the fMRI response to emotional
words. In the premenstrual phase, women with PMDD
showed greater activation in certain areas in response to neg-
ative words (particularly the amygdala) and a decreased acti-
vation to positive words; furthermore, they failed to activate
areas associated with the control of emotional responses.22
Other studies have demonstrated an increased excitability of
the amygdala in the presence of progesterone in healthy
women,23 an area known to be involved in anxiety and mem-
ory. These results suggest possible mechanisms whereby hor-
mones could inﬂuence mood. Of course, hormone-related
changes in mood do not just occur in PMDD; postnatal
depression and puerperal psychosis are other examples where
an understanding of the mechanisms involved would be
useful.
Thus, it may be possible to identify those women who are
potentially at risk of developing a mood disorder in response
to hormonal changes and to establish potential new therapeu-
tic targets. Furthermore, a number of mood-altering/stabilis-
ing drugs also affect the hypothalamic–gonadal axis and thus
alter hormonal status and reproductive function.24 An under-
standing of the interactions between hormones and mood
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apy (HRT) in these patients if it were to be desired.
Postnatal bonding and parenting behaviour
Bonding between new parents and their baby is something we
all know to be important, and in our day-to-day practice, we
take great care to identify antenatally those women we fear
may have difﬁculties bonding and try to prevent traumatic
intrapartum and postnatal events from interfering with this
important process. However, the neural processes involved in
parental behaviour and why these may go wrong in unex-
pected cases are only just beginning to be unravelled. Animal
(both rat and non-human primate) studies have conﬁrmed
the importance of several hormones (oxytocin, dopamine,
prolactin, and estrogen) in the development of this behaviour
and suggested candidate brain areas that might be involved.
However, it is only recently, with the use of functional imag-
ing, that these networks have been visualised in humans. Per-
haps unsurprisingly, it appears that brain circuits involved in
parenting behaviour have many similarities with areas regu-
lating other social attachments. Furthermore, these circuits
can be activated by both auditory (baby crying) and visual
(pictures of babies’ faces) stimuli and, particularly in mothers,
to a greater extent when these stimuli are from their own
rather than another baby. Components of both empathy
and reward circuits also appear to be involved in normal
healthy parenting responses in humans.25
A number of pathological behaviours such as addiction,
anxiety, and mood disorders are associated with abnormal
function in the circuits identiﬁed in these studies and with
disruption of the normal processes of bonding. Thus, it may
be that knowledge of conditions or personality traits with
similar activation patterns may help us to identify more accu-
rately those at risk of bonding issues and subsequent child
neglect. Furthermore, if fMRI studies are able to identify
which infant-related stimuli are best able to activate these
‘parenting circuits’, these stimuli could then be used as a
component of psychological therapies to enhance emotional
bonding between new parent and baby in those who are
struggling.
Effects of hormones on cognitive function
A perceived alteration in cognitive function is a common
complaint of perimenopausal and menopausal women and
of some women during pregnancy and premenstrually. To
what extent could changes in steroid hormone concentrations
be responsible for this?
The direct effect of progesterone on amygdala function
already discussed may explain the impairment of memory
associated with the premenstrual phase and pregnancy,23
and cognitive function has certainly been shown to decline
around the time of and after the menopause. A number of
studies have suggested a neuroprotective effect of estrogen
therapy, with a reduced risk of dementia and less cognitive
ageing.26,27 However, other work has suggested that there may
be a speciﬁc window when these beneﬁts are seen, as in older
postmenopausal women such effects are not demonstrated.
fMRI allows a more speciﬁc investigation of the brain areas
inﬂuenced by hormonal treatments rather than relying on
the interpretation of results of tests of cognitive function.
Even in healthy, premenopausal women, the ability to per-
form language tasks is signiﬁcantly inﬂuenced by hormonal
status,28,29 and prefrontal cognitive tasks, especially verbal
recall, are improved by estrogen replacement in postmeno-
pausal women.30,31 It had been suggested that the beneﬁcial
effect seen in perimenopausal women was in fact mediated
by the reduction in hot ﬂushes and improved sleep leading
to improved functioning. However, fMRI studies have con-
ﬁrmed that this is not the case.31 Small studies have also
suggested that speciﬁc preparations of HRT may have differ-
ing effects on cognitive function.32 If larger studies conﬁrm
this ﬁnding, this may be a further factor to take into account
when weighing up the risks and beneﬁts of HRT for an indi-
vidual woman.
Imaging of non-brain organs
Pelvic organs
Although originally developed for functional imaging of the
brain, in the last decade the technique of BOLD MRI has been
used to evaluate perfusion and hypoxia in a number of other
organs, including the heart,33 kidney,34 and muscles.35 As
these new applications are in their infancy, most studies are
evaluating their utility in healthy tissues, and as yet, very few
clinical studies have translated these techniques into patients.
This is in contrast to brain imaging, where the neural corre-
lates of a huge variety of functions have been elucidated in
healthy subjects and then subsequently compared with
patients with a variety of relevant pathologies.
In the myometrium, it has been shown that the two layers
(outer and junctional zone) function differently, and, as
would be expected, their function varies across the phases
of the menstrual cycle.36 It should therefore be possible to
investigate a number of pathological conditions including
dysmenorrhoea, adenomyosis, and perhaps even unexplained
infertility using this technique. A greater understanding of the
functional role of the myometrium in these conditions may
suggest novel therapies.
As good results have been obtained imaging skeletal mus-
cle elsewhere in the body, another obvious site to consider
would be the pelvic ﬂoor, where other functional imaging
techniques, such as cine-MRI, have already been used in
women with prolapse.37 As can be seen from Figure 1, any
stimulus that causes oxygen consumption via metabolic
activity can be detected by changes in the BOLD signal.
BOLD MRI could therefore be useful to identify abnormal
BOLD fMRI in obstetrics and gynaecology
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tension myalgia, a cause of pelvic pain and dyspareunia.38
Other possible applications include investigating areas of
relative hypoxia or hyperperfusion within the pelvis as has
been hypothesised to occur in primary dysmenorrhoea and
in pelvic venous congestion.
Fetus
MRI is increasingly being used for prenatal diagnosis when
the information provided by ultrasound is insufﬁcient;39
however, recent work has suggested that BOLD fMRI may
also have a role in obstetrics.
The delivery of oxygen to tissues is crucial to the devel-
oping fetus. Both in utero and postnatal cord blood samples
have shown growth-restricted fetuses to be hypoxic and aci-
dotic when compared with normally grown fetuses.40,41
However, a noninvasive test to monitor fetal oxygenation
or identify those fetuses at risk of hypoxia and subsequent
growth restriction does not exist. It has been shown that
maternal oxygen breathing in women in the third trimester
signiﬁcantly increases the MR signal from the fetal liver,42
suggesting that BOLD fMRI may be a suitable technique to
use. This has been investigated further in animals (although
not yet in humans). It can be seen from Figure 3 that in
sheep, maternal hypoxia is associated with fetal hypoxia
and a differential reduction in BOLD signal from a number
of fetal organs.43 As would be expected, the reduction in
p e r f u s i o no fb r a i nt i s s u e sw a sl e s st h a nt h a ts e e ni nt h el u n g ,
heart, and cotyledon and the fetal oxygen saturation corre-
lated signiﬁcantly with the BOLD signal. The larger size of
the human placenta (as opposed to small sheep cotyledons)
should make the assessment of placental perfusion more
feasible and may allow the detection of abnormalities earlier
than currently available methods. Hence, fetal BOLD MRI may
develop into a tool to noninvasively identify and then monitor
organ perfusion in the fetus at risk.
Very little is currently known about the development of
fetal brain function and a better understanding of this area
could inform the management of complicated pregnancies.
A number of studies have investigated structural brain devel-
opment (e.g. cortical folding and myelination) with MRI,
but it is only in the last few years that fetal brain function
has started to be investigated. Brain activation has now been
shown in human fetuses in response to both auditory and
visual stimuli (Figure 4) using similar experimental para-
digms to those used in adults.44 This is a more objective
measure than fetal movements or heart rate changes in
response to stimuli. By examining women of varying gesta-
tion, the age at which these responses develop could be iden-
tiﬁed. Furthermore, the effect of antenatal hypoxia on the
development and maintenance of these pathways could also
be assessed. In combination with structural MRI, fetal fMRI
may have an important role in neurodevelopmental research.
Studies in rats have been able to demonstrate placental
hypoxia with BOLD MRI after giving cloprostenol, a prosta-
glandin F2a analogue45. Thus, this technique could also be
useful in the investigation of drug effects on placental perfu-
sion in animals without the need for invasive monitoring.
Brain imaging using cognitive paradigms in children and
adults who were exposed to certain drugs in utero may also
help us understand in more detail the effects of these drugs on
brain development.46
Conclusions
BOLD fMRI is a technology used widely in many other spe-
cialties, both for basic science research and as a clinically
applicable tool. Here we have described a number of ways
in which it could be applicable to obstetricians and gynaecol-
ogists. These range from brain imaging work looking at
Figure 3. Effect of maternal hypoxia on fetal organ oxygen saturation
and BOLD signal. Scatter plots of data from a single animal during an initial
control period; hypoxia after reduction of maternal oxyhaemoglobin sat-
uration (MatSO2) and recovery. (A) Time course of absolute BOLD signal
intensities (BOLD SI); (B) time course of normalised BOLD signal intensities
(BOLD SI%). FetSO2, fetal oxyhaemoglobin saturation. Reproduced with
permission from Wedegartner U, et al. Radiology 2006;238:872–80.43
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tinence) to aberrant processing of information in disease
states (such as chronic pain and PMDD), to imaging of other
organ systems in both health and disease, in women and their
fetuses. Combining information obtained from structural and
functional imaging methods is particularly powerful, and by
using such complimentary techniques, our knowledge of both
physiology and pathophysiology can be greatly enhanced.
Novel applications such as fetal monitoring have the potential
to make important contributions both to our understanding
and our clinical practice.
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